ASN Highlights: Mumbai, India

Translating Kidney Week into Clinical Practice

This program is designed to help you incorporate the best of the American Society of Nephrology's Kidney Week into patient care. It features highlights from Kidney Week 2016 sessions as well as a synopsis of key nephrology topics, critiques, and perspectives by leading international experts. Join your nephrology colleagues from across India for networking and engaging in provocative discussions with expert faculty.


  • March 4–5, 2017



  • Translation of Kidney Week information into clinical relevance with updates
  • Intensive scientific update on the most relevant and practice changing advances in six core nephrology topics: AKI, ESRD, General Nephrology & CKD, Glomerular Diseases, Hypertension and Transplantation
  • Clinical cases and audience participation
  • Opportunities to engage with the expert faculty


There is no registration fee. Please email to register for this meeting.

Faculty and Scientific Sessions

AKI: Paul M. Palevsky, MD, FASN - View Bio

AKI constitutes a complicating feature of many acute illnesses and represents a significant contributor to morbidity and mortality. AKI is also a prominent cause of CKD. This session delineates novel areas of basic science research that have potential clinical impact in the future. Summaries of current translational projects are presented in a hypothesis-driven format. New clinically important findings are also described and then measured against contemporary evidence-based standards of practice.

ESRD: Vandana Niyyar, MD, FASN - View Bio

This session highlights new information regarding techniques in dialysis, ESRD complications, and ESRD treatments. Vascular access surveillance and monitoring strategies are reviewed. The anemia of CKD and CKD-MBD are discussed in association with best practice treatment, along the continuum of CKD. Novel medical preventive strategies are presented along with dialytic techniques.

General Nephrology & CKD: Tamara Isakova, MD - View Bio

This session provides a rapid review of the pathophysiology and treatments of nephrotoxins, non-glomerular kidney disorders, including diabetic kidney disease, acid-base/electrolyte disorders, and nephrolithiasis. In addition, the epidemiology and newer data regarding renal cystic disorders and masses are reviewed. The associations of cardiovascular disease in CKD are presented and the controversies surrounding estimation of kidney function via estimating equations are described.

Glomerular Diseases: Heather N. Reich, MD, PhD - View Bio

The session devoted to Glomerular Diseases reviews the most "significant" new information in the areas of primary and secondary glomerular disease, vasculitis, and thrombotic microangiopathies. In particular, an emphasis is placed on unpublished material involving clinical (human) studies presented as oral communications, posters, science symposia, and clinical conferences during the previous year's Kidney Week.

Hypertension: Sandra J. Taler, MD - View Bio

Hypertension occurs in the overwhelming majority of cases of CKD, and it represents both cause and consequence of CKD. In this session, mechanistic explanations of high blood pressure are described and presented as the background for emerging therapies. Epidemiological trends in hypertension are reviewed with preliminary results from ongoing clinical trials in CKD and ESRD. Trends in management of hypertension in association with proteinuria, especially that of combination therapies, are critically reviewed. Lastly, new findings regarding pathogenesis and therapy of secondary hypertension and renovascular hypertension are discussed.

Transplantation: John J. Friedewald, MD, FASN - View Bio

This session enumerated the treatment and management of the complications of kidney transplantation, modalities of immunosuppressive therapies, and new findings regarding the pathobiology of allograft rejection. The results of new clinical trials involving current and future medical treatments are described and critically reviewed. Finally, preliminary data from late-breaking research studies are reviewed.

Moderator: TBD


Supported by an unrestricted educational grant from:

In association with: